Yonsei University: Ischemic Stroke trials

The registry lists 11 Ischemic Stroke studies with Yonsei University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 3Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry)RecruitingNCT07724171
• CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioNNot yet recruitingNCT06770426Phase 3
• Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2)RecruitingNCT06677970Phase 3
• Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain InjuryRecruitingNCT02018406Phase 1/2
• Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)TerminatedNCT04839224Phase 3
• First-pass Recanalization With EmboTrap II in Acute Ischemic Stroke (FREE-AIS)Status unknownNCT04310306
• Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)CompletedNCT04205305Phase 4
• SMART-EST(Specialized Multi-center Attributed Registry of sTroke - EndovaScular or Thrombolytic Therapy)Active, not recruitingNCT04066556
• Rescue Stenting for Failed Endovascular Thrombectomy in Acute Ischemic Stroke (ReSET)CompletedNCT03993340
• Collateral-based reSetting of Endovascular Treatment Time Window for Stroke (CoSETS)TerminatedNCT03234634Not applicable
• Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) Study: Development of Patient Selection Criteria Using CT Images and Accompanying Diseases for Efficient Intravenous Thrombolytic and Intra-arterial Recanalization Therapy in Acute Ischemic StrokeCompletedNCT02964052